This topic contains a solution. Click here to go to the answer

Author Question: The heavy, running lower voice line in Baroque music is called A) basso continuo. B) sequence. C) ... (Read 71 times)

imowrer

  • Hero Member
  • *****
  • Posts: 514
The heavy, running lower voice line in Baroque music is called
 
  A) basso continuo. B) sequence. C) counterpoint. D) stretto.

Question 2

Which does NOT characterize an oratorio?
 
  A) elaborate scenery and staging B) choruses
  C) arias D) recitatives



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

anyusername12131

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

A

Answer to Question 2

A




imowrer

  • Member
  • Posts: 514
Reply 2 on: Jul 25, 2018
Great answer, keep it coming :)


yeungji

  • Member
  • Posts: 319
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library